Professor Dominik Fischer
Consultant Ophthalmologist & Vitreoretinal Surgeon
- 81 publications
- 150+ conferences
- 5613 citations
Professional Title
Consultant Ophthalmologist & Vitreoretinal Surgeon
Years of Experience
20+
Credentials & Memberships
- European Society of Cataract and Refractive Surgeons
- Royal College of Ophthalmology
- British and Eire Association of Vitreoretinal Surgeons
- Association for Research in Vision and Ophthalmology
- American Academy of Ophthalmology,
- European Society of Retina Specialists
- Prestigious Club Jules Gonin
Bio Summary
Professor Dominik Fischer is an award-winning consultant ophthalmic surgeon specialising in cataracts and retinal disorders.
He is a seasoned vitreoretinal surgeon who is also passionate about providing highly personalised care utilising the latest technology and developments in ophthalmic surgery.
As internationally renowned expert, he holds several appointments in the UK, EU and USA and is often tasked with training other surgeons across the world.
He is an NHS Consultant Ophthalmic Surgeon at the Oxford Eye Hospital and Professor of Ophthalmology at the University of Oxford, with further academic appointments as Professor of Ophthalmology at the University of Tübingen (Germany) and the University of Lausanne (Switzerland). He is appointment member of the External Advisory Committee of the University of Miami Mark J. Daily Inherited Retinal Disease Research Centre at the Bascom Palmer Eye Institute.
After receiving his MD (summa cum laude) for research performed as Visiting Scholar at the University of Pennsylvania, he completed his specialty (Ophthalmology) and subspecialty training in Tübingen and received his second doctorate (DPhil) at Oxford. He is the recipient of more than 25 awards, among them the Leonhard Klein award for the advancement of vitreoretinal surgery and the Senator H. Wacker award for scientific contributions to the field of retinal disease.
He is an active member of several flagship societies in the field (European Society of Cataract and Refractive Surgeons, Royal College of Ophthalmology, British and Eire Association of Vitreoretinal Surgeons, Association for Research in Vision and Ophthalmology, American Academy of Ophthalmology, European Society of Retina Specialists and the prestigious Club Jules Gonin).
Career Highlights
- 2020 Principal investigator, first-in-man gene therapy for PDE6A associated Retinitis Pigmentosa
- 2019 Chief investigator, world’s first ocular gene therapy post-marketing study (voretigene neparvovec)
- 2018 World’s first treatment in a phase III retinal gene therapy trial for choroideremia (NightStar)
- 2017 First genetically stable IND for XLRP gene therapy
- 2016 First phase II retinal gene therapy trial in Germany (investigator-initiated trial for choroideremia)
- 2015 World’s first gene therapy targeting cones (also world first gene therapy for achromatopsia, world first retinal gene therapy with AAV8 and first retinal gene therapy in Germany)
Areas of Expertise
- Cataract surgery
- Vitreoretinal surgery
- Age-related macular degeneration (AMD)
- Diabetic retinopathy/maculopathy
- Macular hole
- Epiretinal membrane (ERM)
- Retinal detachment and other retinal tears/retinal emergencies
- Retinal vein occlusions and other retinal vascular disorders
- Macular dystrophies and inherited retinal diseases (including gene-therapy research involvement)